Skip to content
zameds

Gaviscon Liquid Peppermint

No structure available

This product's active ingredient could not be matched to a single known compound.

Registration

Applicants
1
Registrations
1

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Reckitt Benckinser Pharmaceuticals (Pty) LtdCertificate held by Reckitt Benckiser Pharmaceuticals (Pty) LtdGaviscon liquid peppermint10 ml290641Not determinedPIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Gaviscon liquid peppermint

EACH 10 ml SUSPENSION CONTAINS SODIUM ALGINATE 500 mg

10 mlSuspension29064129/11.10/0641Approved 26 August 2025RegisteredNot determinedPIPIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

SAHPRA documents

Research articles

Loading...
Loading PubMed articles